- Location
NIH
"-
Particle Sciences Has Completed Manufacturing of Vaginal Rings with New Architecture
Oct 15, 2013US-based drug delivery contract development and manufacturing organization (CDMO) Particle Sciences has completed manufacturing of vaginal rings with new architecture, essentially a powdered filled tube intended for HIV prevention. The ...
Tags: HIV Prevention, Particle Sciences
-
Sorrento Has Acquired Sherrington Pharmaceuticals for Chronic Pain Treatment
Oct 12, 2013US-based development-stage biopharmaceutical firm Sorrento Therapeutics has acquired Sherrington Pharmaceuticals (Sherrington), a company that provides chronic pain treatment for end-stage cancer patients and other severe pain indications. ...
Tags: Drug, Chronic Pain Treatment
-
MAX BioPharma Licensed The Small Molecule Oxysterols From University of California
Oct 10, 2013MAX BioPharma has exclusively licensed the small molecule oxysterols from University of California, Los Angeles and Johns Hopkins University in the US. The pharmaceutical company has also received a Small Business Innovation Research ...
-
Optivia Biotechnology Has Secured a $1.8m Two-Year Phase II SBIR Grant
Oct 9, 2013Optivia Biotechnology has secured a $1.8m two-year Phase II small business innovation research (SBIR) grant, from the National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH). The federal grant is expected to ...
-
Genia Consortium to Develop Genia's Nanopore-Based DNA Sequencing Platform
Oct 1, 2013Genia Technologies in consortium with Columbia University and Harvard Medical School, has secured a three-year $5.25m grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH), to develop ...
Tags: Health, Medicine, DNA Sequencing Platform
-
Soligenix Has Secured a Contract Worth $6.4m
Sep 27, 2013Biopharmaceutical company Soligenix has secured a contract worth $6.4m from the US Department of Health and Human Service's National Institutes of Health (NIH), for the advanced preclinical development of OrbeShield (oral beclomethasone ...
-
$2.5m Sbir Grant Is Secured by Adaptive Biotechnologies
Sep 17, 2013Adaptive Biotechnologies, a biotechnology company, has secured a $2.5m Phase II small business innovation research (SBIR) award from the National Heart, Lung, and Blood Institute, a division of the NIH. The award is granted to ...
Tags: Adaptive Biotechnologies, Medicine
-
NovelMed Therapeutics Has Received a Combined $1.43m SBIR Grant
Sep 12, 2013NovelMed Therapeutics has received a combined $1.43m small business innovation research (SBIR) grant from the National Institutes of Health (NIH) to further develop its anti-complement antibody for orphan disease. The company will use the ...
-
Sanford-Burnham Has Teamed up with Pharma Major Pfizer
Aug 15, 2013Sanford-Burnham Medical Research Institute (Sanford-Burnham) has teamed up with pharma major Pfizer, to identify new therapeutic targets to prevent and treat obesity and diabetes complications. With plans to discover new treatments for ...
Tags: Sanford-Burnham, Pfizer
-
BioFire Diagnostics Begun Clinical and Analytical Studies to Evaluate GI Panel
Aug 2, 2013US-based BioFire Diagnostics has begun clinical and analytical studies to evaluate its FilmArray Gastrointestinal (GI) Panel. This clinical study is being conducted at several hospital-based clinical laboratories in the US and is funded ...
-
A Free Online Database Launched to Check The Ingredients and Claims of Brand Name Products
Jun 20, 2013Now you don't have to depend on the store clerk at the health food store to help you compare and choose a dietary supplement. A free online database launched this week let's you check the label and browse the ingredients and claims of brand ...
-
The USFDA Has Granted Priority Review Designation for Investigational Agent Metreleptin
Jun 6, 2013The USFDA has granted priority review designation for investigational agent Metreleptin, jointly developed by Bristol-Myers Squibb Company and AstraZeneca, for the treatment of metabolic disorders associated with rare forms of ...
-
Partek Has Partnered with Kennedy Krieger Institute to Develop Commercial Software
May 23, 2013Partek Incorporated has partnered with Kennedy Krieger Institute to develop commercial software, which will aid in analyzing genomic data from patients suffering with autism spectrum disorder and mental health disorders. Analyzing human ...
Tags: Partek, Kennedy Krieger Institute
-
Corgenix Medical Has Received The Notification of CE Mark
May 13, 2013Corgenix Medical has received the notification of CE Mark for its Relasv antigen rapid test for Lassa fever diagnosis. Relasv is the diagnostic test developed by Corgenix and members of the Viral Hemorrhagic Fever Consortium (VHFC), a ...
Tags: Corgenix Medical, Rapid Test
-
SPIE Were Encouraged to See Proposed Increases in Funds for Research and Development
Apr 16, 2013SPIE leaders said they were encouraged to see proposed increases in funds for scientific research and development and a greater emphasis on STEM education in President Obama’s 2014 budget proposal released last Wednesday. At the same ...
Tags: SPIE Leaders, Science Funding
